logo
#

Latest news with #StephenHelmsley

UnitedHealth stock sinks 4.7% after company confirms DOJ investigation into Medicare billing practices
UnitedHealth stock sinks 4.7% after company confirms DOJ investigation into Medicare billing practices

Yahoo

time4 days ago

  • Business
  • Yahoo

UnitedHealth stock sinks 4.7% after company confirms DOJ investigation into Medicare billing practices

UnitedHealth (UNH) stock fell 4.7% on Thursday after the insurance giant disclosed in a regulatory filing that it is facing an investigation from the Department of Justice into its Medicare billing practices. Following news reports from the Wall Street Journal about insurance billing techniques used by UnitedHealth and other large medical insurers, the Justice Department's healthcare fraud unit began making criminal and civil requests of the company, according to the filing. "The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process," UnitedHealth said in its disclosure. "The Company has a long record of responsible conduct and effective compliance." The insurer also said it has "proactively launched its own initiative to conduct third party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services." The Wall Street Journal's reporting, first published in December 2024, documented several ways in which United and other major insurers have received billions of dollars in extra payments from the federal Medicare Advantage system, which allows approved private companies to provide health benefits in lieu of the federally managed Medicare system. These include companies taking on extra, and sometimes incorrect, diagnoses to patient profiles when those rulings had not been made by the doctors actually treating the patients, allowing the insurers access to extra payouts from the Medicare program, among other tactics. The health insurance giant has been facing a probe from the Justice Department into possible Medicare fraud since at least the summer of 2024, according to the Wall Street Journal's reporting. UnitedHealth has been embroiled in a series of leadership controversies and financial setbacks over the last year, with its stock falling about 50% over that period. In May 2024, the company and several senior executives — including founder and group chairman Stephen Helmsley, and then-UnitedHealthcare CEO Brian Thompson — were sued by a Hollywood-based pension fund for insider trading in a lawsuit alleging executives sold more than $100 million in stock after the company found out it was facing an antitrust probe by the Department of Justice but before the investigation was publicly disclosed. Seven months later, in December, Thompson was shot and killed in Manhattan the morning of the company's annual investor meeting. Reactions across the country centered on anger toward UnitedHealthcare over its treatment of people on its insurance, including denial of claims. When the company reported earnings a month later, the results showed revenue missed analyst estimates and the insurer's medical care ratio — which measures how much of collected premiums are spent by the insurer on medical care — spiked. The stock dropped around 5% after the release. Three months later, the company's first quarter earnings report saw it slash its adjusted earnings per share guidance and sent shares down over 22%, its worst single-day performance since 1998. The next month, UnitedHealth's CEO Andrew Witty abruptly stepped down while the company pulled its annual forecast. Helmsley, who had previously moved to a role as group chairman, was quickly appointed as CEO to replace Witty. He was granted a pay package that includes a $1 million salary and $60 million in stock options that will vest after three years. That same month, the company suspended its annual forecast entirely, sending shares tumbling by roughly 16%. And in a final blow, UnitedHealth accidentally leaked a memo to STAT News in June that listed internal talking points on topics including the use of AI models to deny claims. Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Click here for in-depth analysis of the latest stock market news and events moving stock prices

UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe
UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe

Yahoo

time15-05-2025

  • Business
  • Yahoo

UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe

UnitedHealthcare (UNH) stock fell as much as 17% early Thursday, reaching its lowest levels in five years and marking a more than 50% drop over the last month as negative headlines for the insurance giant continue to add up. Thursday's plunge follows a new report in The Wall Street Journal released late Wednesday that said the company is facing a criminal investigation related to possible Medicare fraud. In a statement on Wednesday, UnitedHealth called the story "deeply irresponsible," referring to a "supposed" investigation. UNH added in its statement that it stands by the integrity of its Medicare Advantage program. On Tuesday, the company announced its former CEO, Stephen Helmsley, would replace Andrew Witty in a surprise move that sent shares of the company down nearly 20%. The company also pulled its 2025 forecast in making the executive change. Wall Street analysts said following the leadership and forecast announcements, the company is unlikely to receive the benefit of the doubt from investors until some semblance of stability can be offered. Thursday's sharp reaction to the latest negative developments for the company is another case in point. As Yahoo Finance's Anjalee Khemlani noted earlier this week, the company's challenges are many: increased costs, political pressure over its size, and scrutiny by the Federal Trade Commission and Department of Justice are all weighing on the business. Congress has also put the spotlight on its market power as a large pharmacy benefits manager (PBM). Furthermore, the company has faced questions about its use of artificial intelligence in claims processing and a large cybersecurity attack on its Change Healthcare subsidiary. The company also suffered significant public backlash following the killing of former executive Brian Thompson in December, and investors are suing the company for downplaying the impact from that tragedy. Questions about claim denials and fury about overall insurance industry practices were directed at UnitedHealth in the aftermath of the killing. Sign in to access your portfolio

UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe
UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe

Yahoo

time15-05-2025

  • Business
  • Yahoo

UnitedHealth stock craters, hitting 5-year low after new report reveals possible Medicare fraud probe

UnitedHealthcare (UNH) stock fell as much as 17% early Thursday, reaching its lowest levels in five years and marking a more than 50% drop over the last month as negative headlines for the insurance giant continue to add up. Thursday's plunge follows a new report in The Wall Street Journal released late Wednesday that said the company is facing a criminal investigation related to possible Medicare fraud. In a statement on Wednesday, UnitedHealth called the story "deeply irresponsible," referring to a "supposed" investigation. UNH added in its statement that it stands by the integrity of its Medicare Advantage program. On Tuesday, the company announced its former CEO, Stephen Helmsley, would replace Andrew Witty in a surprise move that sent shares of the company down nearly 20%. The company also pulled its 2025 forecast in making the executive change. Wall Street analysts said following the leadership and forecast announcements, the company is unlikely to receive the benefit of the doubt from investors until some semblance of stability can be offered. Thursday's sharp reaction to the latest negative developments for the company is another case in point. As Yahoo Finance's Anjalee Khemlani noted earlier this week, the company's challenges are many: increased costs, political pressure over its size, and scrutiny by the Federal Trade Commission and Department of Justice are all weighing on the business. Congress has also put the spotlight on its market power as a large pharmacy benefits manager (PBM). Furthermore, the company has faced questions about its use of artificial intelligence in claims processing and a large cybersecurity attack on its Change Healthcare subsidiary. The company also suffered significant public backlash following the killing of former executive Brian Thompson in December, and investors are suing the company for downplaying the impact from that tragedy. Questions about claim denials and fury about overall insurance industry practices were directed at UnitedHealth in the aftermath of the killing. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store